Cholesterol Metabolism and Immunotherapy in Gastric Cancer
Author Information
Author(s): Zhu Chengjun, Yan Mengpei, Zhang Zhijun, Shen Yikai, Wang Wangwen, Chen Zetian, Cai Changsheng, Liu Hongda, Xu Zekuan, Li Zheng
Primary Institution: The First Affiliated Hospital of Nanjing Medical University
Hypothesis
The study investigates the role of cholesterol metabolism-related genes (CMRGs) in predicting prognosis and immunotherapy efficacy in gastric cancer.
Conclusion
The study highlights the importance of CMRGs in gastric cancer, showing that higher cholesterol scores are associated with better survival and sensitivity to immunotherapy.
Supporting Evidence
- Patients with high cholesterol scores showed improved survival rates.
- High cholesterol scores correlated with increased tumor mutational burden and microsatellite instability.
- The study validated the prognostic score in real-world cohorts undergoing immunotherapy.
Takeaway
This study found that cholesterol levels in cancer can help doctors predict how well patients will respond to treatments.
Methodology
The study analyzed transcriptome data from 675 gastric cancer patients, identifying cholesterol metabolism-related genes and developing a prognostic scoring system.
Limitations
The study's metabolic classifications were derived from public datasets, and their clinical relevance requires further validation.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website